1. A pilot study of using 25 mg BD sacubitril/valsartan effect in reverse LV remodeling: A single-center experience. (December 2022) Authors: Othman, M.K.; Yusof, Z.; Wu, J.T.; Ibrahim, S.; Ismail, M.F.; MAM, Ismail; Zakaria, A.Z.; Hussin, S.A.; NAH, Nik Mohd Zaid; Zakaria, S.; Isa, W.Y.H.W. Journal: International journal of cardiology Issue: Volume 369(2022)Supplement Page Start: 5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗